$343,000 Settlement with American International Biotechnology, LLC Resolves False Claims Act Allegations
PITTSBURGH - American International Biotechnology, LLC ("AIB") has agreed to pay the United States $343,739.45 to settle False Claims Act allegations, United States Attorney David J. Hickton announced today. The settlement resolves allegations that AIB violated the False Claims Act by obtaining improper referrals for genetic tests billed to the Medicare program.
- Date:July 22, 2014
- Agency:U.S. Attorney
- Criminal and Civil Actions